Shanghai ERP Biotechnology (revision 21)
Old revision·17:54, 1 Sep 2025·GIP_Genoveva
| Shanghai ERP Biotechnology Co., Ltd. | |
|---|---|
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| Legal name | Shanghai ERP Biotechnology Co., Ltd. |
| Trading name | ERP |
| Other designations | ERP Biotech, Shanghai ERP Biotechnology |
| Identity | |
| Founded | 2018 |
| Headquarters | Shanghai, China |
| Industry | Research-compound supply |
| Shop domain | Visit ERP |
| Organisation infobox · conventions | |
Shanghai ERP Biotechnology Co., Ltd. (trading as ERP; erpbiotechnology.com) is a research-compound supplier trading as ERP from Shanghai, China, incorporated in 2018, supplying research peptides, SARMs and raw materials with batch documentation and tracked shipping.[1][2]
The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]Incorporated in 2018 in Shanghai, the organisation is one of six covered here registered in that city.[1] Its short designation coincides with a widely used business-software acronym, which has no bearing on the entity but does make it unusually difficult to research: a search for the trading name returns overwhelmingly unrelated results. The article records that as a practical observation for readers attempting verification.
The documentary base is the registry record, the organisation's own material and purchaser reports.
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe conventional practice: lyophilised material in crimped vials, batch certificate with purity and appearance, insulated packaging on the incretin lines.[5] Water figures have appeared on a minority of the submitted certificates.[6]
Product range
[edit]| Class | Representative listings | Documentation reported |
|---|---|---|
| Incretin analogues | Semaglutide, tirzepatide, retatrutide | Certificate, purity; water on a minority |
| Research peptides | Repair and secretagogue peptides | Certificate, purity |
| SARMs | Bulk | Certificate, purity |
| Raw materials and oils | Bulk | Certificate, limited detail |
References
- ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
- ^ United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.